Other OTC - Delayed Quote USD

Innovent Biologics, Inc. (IVBXF)

5.0000 +0.1100 (+2.25%)
At close: April 26 at 3:06 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
17,588,845.0000
16,243,713.0000
11,834,996.0000
Total Liabilities Net Minority Interest
6,858,896.0000
5,913,316.0000
3,055,226.0000
Total Equity Gross Minority Interest
10,729,949.0000
10,330,397.0000
8,779,770.0000
Total Capitalization
12,945,382.0000
12,353,658.0000
9,704,948.0000
Common Stock Equity
10,729,949.0000
10,330,397.0000
8,779,770.0000
Capital Lease Obligations
125,075.0000
108,665.0000
26,390.0000
Net Tangible Assets
9,531,786.0000
9,558,203.0000
8,747,145.0000
Working Capital
8,007,510.0000
8,500,802.0000
7,980,830.0000
Invested Capital
13,833,382.0000
12,718,658.0000
9,959,948.0000
Tangible Book Value
9,531,786.0000
9,558,203.0000
8,747,145.0000
Total Debt
3,228,508.0000
2,496,926.0000
1,206,568.0000
Net Debt
2,087,268.0000
1,028,853.0000
--
Share Issued
1,534,406.9830
1,462,108.6640
1,402,775.9970
Ordinary Shares Number
1,534,406.9830
1,462,108.6640
1,402,775.9970
12/31/2020 - 9/4/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers